Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma

2016/01/12 by Jordi Bruix, Maria Reig, María Reig +1 · 30 citations
Medicine · #Hepatocellular Carcinoma Treatment and Prognosis #Liver Disease Diagnosis and Treatment #Hepatitis C virus research

paper · doi:10.1053/j.gastro.2015.12.041

Citations

• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
• Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis
• Liver disease induced by radioembolization of liver tumors

Cited by

• Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices
• Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
• NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL‐6/JAK2/STAT3 pathway activation
• Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma
• BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
• Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development. [europepmc]
• Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. [europepmc]
• Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway. [europepmc]
• Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress. [europepmc]
• Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial. [europepmc]
• Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma. [europepmc]
• A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma. [europepmc]
• Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. [europepmc]
• Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. [europepmc]
• Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. [europepmc]
• Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. [europepmc]
• Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study. [europepmc]
• A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE. [europepmc]
• Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions. [europepmc]
• Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment. [europepmc]
• A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements. [europepmc]
• Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. [europepmc]
• Carbohydrate antigen 19-9 - tumor marker: Past, present, and future. [europepmc]
• Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies. [europepmc]
• Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study. [europepmc]
• Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. [europepmc]
• MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. [europepmc]
• Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11. [europepmc]
• BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. [europepmc]
• Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study. [europepmc]